Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 4;13:5033–5046. doi: 10.2147/OTT.S241503

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Ouyang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Effect of MT1JP on breast cancer cells in vivo. (A) Tumor volume of different experimental groups at different time points. **P<0.01, ***P<0.001, compared with Vector group; #P<0.05, ^##P<0.01, compared with MT1JP group. (B) Tumor weight of different experimental groups ***P<0.001, compared with the Vector group; ^##P<0.01, compared with the MT1JP group. (C) Pathology of different experimental groups by HE staining (×400 magnification). (D) Relative gene expression in different experimental groups by RT-qPCR assay. ***P<0.001, compared with the Vector group; ^##P<0.01, compared with the MT1JP group. (E) Apoptotic cell number of different tissues by TUNEL assay (×400 magnification) ***P<0.001, compared with the Vector group; ^##P<0.01, compared with the MT1JP group.